Johnson & Johnson s Covid-19 vaccine gets unanimous vote from FDA advisers vox.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vox.com Daily Mail and Mail on Sunday newspapers.
Vaccine supply increasing, but thousands in state are still waiting for COVID-19 shots
For now, demand is heavy and supply limited in Massachusetts
By Robert Weisman Globe Staff,Updated February 25, 2021, 7:51 a.m.
Email to a Friend
Tamara Smith, an RN at the new Curative Mass Vaccination site in Dartmouth.Jonathan Wiggs/Globe Staff
Vaccine makers Pfizer and Moderna are cranking up production. The feds are boosting allotments to states. The Baker administration is opening big new vaccination sites. And a long-awaited third vaccine, from Johnson & Johnson, could win US clearance in days and begin shipping next week.
But none of that means the Hanovers of Boxborough, newly eligible for COVID-19 shots, will be able to get them soon.
Here is the
Radio Boston rundown for Feb. 24. Tiziana Dearing is our host.
It s a big week for the Johnson and Johnson coronavirus vaccine. The FDA deemed it safe and effective today, and it appears to be more effective than originally reported against the newer, more infectious variants of the coronavirus. That brings the vaccine a critical step closer to being authorized for emergency use. We speak with Dr. Dan Barouch, the director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center. His lab helped design the Johnson & Johnson vaccine. We also speak with WBUR s Carey Goldberg about the latest vaccine and other coronavirus news.
We speak about what this means with Dr. Dan Barouch, the director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center. We also speak with WBUR's Carey Goldberg, one last time, about the latest vaccine and coronavirus news.
Type 2 diabetes mellitus
Massachusetts list of conditions that qualify for vaccination in phase 2 is a complete replica of the CDC s above, except it opted to also include asthma (moderate-to-severe).
Now, as Massachusetts makes vaccines available for residents with two or more COVID risk conditions, many residents are trying to figure out if they qualify.
Take Suzy Dolan, a Cambridge resident diagnosed with type 1 diabetes. Dolan says the advice from her doctors has been clear since the beginning of the pandemic.
“ ‘If you get COVID, you will get really sick,’ is basically what they said,” she explains.
Dolan also has a second high-risk condition: asthma. At an appointment last week, she asked doctors who help manage her diabetes if she should be vaccinated. They talked about a state form that patients with at least two qualifying conditions will sign, a written way to swear that they are eligible.